Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 84,146 |
|
|||||
| News | (1) | ||||||
| Day High | 34.11 | Low High |
|||||
| Day Low | 32.09 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.52 | 4.71% | 33.81 | 14:03:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 32.14 | 32.09 | 34.11 | 32.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,231 | 84,146 | $ 33.31 | $ 2,803,168 | - | 12.57 - 40.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:03:18 | 1 | $ 33.8507 | USD |
Tarsus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.16B | 34.22M | - | 17.45M | -135.89M | -3.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tarsus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 34.50 | 36.565 | 31.72 | 33.35 | 408,768 | -0.69 | -2.00% |
| 1 Month | 34.16 | 38.46 | 31.72 | 35.35 | 572,400 | -0.35 | -1.02% |
| 3 Months | 27.94 | 40.40 | 27.10 | 33.50 | 740,818 | 5.87 | 21.01% |
| 6 Months | 12.94 | 40.40 | 12.84 | 26.28 | 697,510 | 20.87 | 161.28% |
| 1 Year | 14.73 | 40.40 | 12.57 | 23.20 | 536,756 | 19.08 | 129.53% |
| 3 Years | 32.00 | 40.40 | 10.8001 | 21.71 | 235,843 | 1.81 | 5.66% |
| 5 Years | 18.30 | 63.69 | 10.8001 | 22.41 | 211,524 | 15.51 | 84.75% |
Tarsus Pharmaceuticals Description
| Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |
